circRNA dysregulation as neurodegeneration biomarker and exploratory therapeutic biology
🧪 Overview
Neuronal circRNAs may reflect synaptic, mitochondrial, and RNA-regulatory disruption in neurodegenerative disease. The strongest near-term use is biomarker discovery and stratification; therapeutic manipulation remains low-confidence because causality, stoichiometry, delivery, and m6A specificity are unresolved.
🧬 Mechanism
⚖️ Evidence
No linked papers recorded for this hypothesis yet.
🏥 Translation
🧬 3D Protein Structure — CIRCHOMER1;
No curated PDB or AlphaFold mapping for CIRCHOMER1; yet. Search RCSB →
💉 Clinical Trials
No clinical trials data linked to this hypothesis yet.
No curated ClinVar variants loaded for this hypothesis.
Run scripts/backfill_clinvar_variants.py to fetch P/LP/VUS variants.
No DepMap CRISPR Chronos data found for circHomer1; circCfl1; ALKBH5; YTHDF2.
Run python3 scripts/backfill_hypothesis_depmap.py to populate.
🏆 Tournament
🏆 Arenas / Elo
📊 Market Indicators
💾 Resource Usage
No resource usage or linked notebooks recorded for this hypothesis yet.
▸Metadatasource: v1_phase_c_backfill · origin_type: debate_synthesizer
| source | v1_phase_c_backfill |
| origin_type | debate_synthesizer |
| _schema_version | 1 |